End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 18 | Pharmaceutical Groups Idorsia, Viatris Finalize Collaboration to Develop Selatogrel, Cenerimod | MT |
Mar. 12 | Insud Pharma S.L.U. acquired Women Healthcare business of Viatris Inc.. | CI |
Chart calendar Mylan Inc
Upcoming events on Mylan Inc
Past events on Mylan Inc
2024-03-07 | Ex-dividend day |
2024-02-28 08:30 am | Q4 2023 Earnings Call |
2024-02-28 06:30 am | Q4 2023 Earnings Release |
2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
2023-12-15 11:00 am | Annual General Meeting |
2023-11-21 | Ex-dividend day |
2023-11-15 04:30 am | Jefferies London Healthcare Conference |
2023-11-07 05:00 pm | Q3 2023 Earnings Call |
2023-11-07 04:02 pm | Q3 2023 Earnings Release |
2023-08-22 | Ex-dividend day |
2023-08-07 08:30 am | Q2 2023 Earnings Call |
2023-08-07 06:59 am | Q2 2023 Earnings Release |
2023-06-13 04:20 pm | Goldman Sachs Global Healthcare Conference |
2023-05-22 | Ex-dividend day |
2023-05-08 08:30 am | Q1 2023 Earnings Call |
2023-05-08 06:59 am | Q1 2023 Earnings Release |
2023-04-24 05:30 pm | American Academy of Neurology Meeting - Poster #014 |
2023-03-07 | Ex-dividend day |
2023-02-27 08:30 am | Q4 2022 Earnings Call |
2023-02-27 06:00 am | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11 501 11 537 -0.32% | 11 946 12 273 -2.66% | 17 886 17 881 0.03% | 16 263 16 372 -0.67% | 15 427 15 465 -0.25% | 15 200 |
EBITDA Million USD | Released Forecast Spread | 3 540 3 500 1.12% | 3 654 4 483 -18.49% | 6 426 6 464 -0.59% | 5 777 5 852 -1.29% | 5 124 5 197 -1.4% | 4 893 |
EBIT Million USD | Released Forecast Spread | 3 264 3 212 1.62% | 3 376 3 864 -12.61% | 6 046 6 111 -1.07% | 5 475 5 566 -1.62% | 4 725 4 851 -2.6% | 4 568 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 154 807 -80.87% | -721 3 677 -119.61% | -664 -580 -14.55% | 2 813 878 220.41% | 203 1 198 -83.06% | 4 100 |
Net income Million USD | Released Forecast Spread | 16,8 427 -96.07% | -670 1 449 -146.24% | -1 269 -952 -33.29% | 2 079 1 328 56.46% | 54,7 812 -93.26% | 1 885 |
EPS USD | Released Forecast Spread | 0,03 0,81 -96.3% | -1,11 1,62 -168.59% | -1,05 -0,77 -36.36% | 1,71 1,01 69.62% | 0,05 0,84 -94.02% | 1,45 |
Announcement Date | 27/02/20 | 01/03/21 | 28/02/22 | 27/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 342 4 337 0.11% | 4 192 4 258 -1.55% | 4 117 4 175 -1.39% | 4 078 4 136 -1.39% | 3 876 3 988 -2.8% | 3 729 3 812 -2.18% | 3 919 3 862 1.45% | 3 942 3 997 -1.37% | 3 837 3 877 -1.03% | 3 727 | 3 835 | 3 880 | 3 855 |
EBITDA Million USD | Released Forecast Spread | 1 416 1 481 -4.39% | 1 586 1 445 9.8% | 1 482 1 443 2.73% | 1 498 1 431 4.69% | 1 211 1 288 -6% | 1 341 1 222 9.69% | 1 306 1 255 4.04% | 1 360 1 293 5.2% | 1 117 1 220 -8.44% | 1 270 | 1 193 | 1 257 | 1 158 |
EBIT Million USD | Released Forecast Spread | 1 314 1 383 -5.04% | 1 551 1 375 12.82% | 1 425 1 364 4.46% | 1 415 1 368 3.4% | 1 085 1 166 -6.96% | 1 255 1 151 9.02% | 1 226 1 178 4.12% | 1 257 1 208 4.05% | 987 1 100 -10.29% | 1 122 | 1 156 | 1 183 | 1 086 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -204 -119 -71.34% | 528 48,0 998.96% | 402 260 54.69% | -855 140 -710.71% | |||||||||
Net income Million USD | Released Forecast Spread | -264 53,2 -595.86% | 399 149 167.56% | 314 234 34.21% | 354 357 -0.78% | 1 011 257 292.86% | 225 154 46.31% | 264 225 17.13% | 332 246 35.03% | -766 114 -771.58% | 167 | 146 | 191 | 138 |
EPS USD | Released Forecast Spread | -0,22 0,41 -154.32% | 0,33 0,08 304.11% | 0,26 0,19 36.43% | 0,29 0,42 -31.07% | 0,83 0,15 453% | 0,19 0,23 -15.82% | 0,22 0,20 8.2% | 0,27 0,34 -20.08% | -0,64 0,26 -344.8% | 0,15 | 0,15 | 0,23 | 0,27 |
Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 07/11/23 | 28/02/24 | - | - | - | - |
Past sector events for Mylan Inc
- Stock
- Equities
- Stock Viatris Inc.
- Stock Mylan Inc - Nasdaq
- Calendar Mylan Inc